Federal Register / Vol. 72, No. 248 / Friday, December 28, 2007 / Notices 73827 

Health Maintenance Organization 

(HMO). 

The data to be collected for this 

project will be in two forms: (a) answers 

to a screener questionnaire designed to 

identify and recruit eligible participants, 

and (b) verbal reports—i.e., focus group 

participants’ answers to questions posed 

by the moderator and reactions to 

comments of other group members. The 

focus group discussions will be audiotaped with participants’ consent and 

transcribed for analysis purposes. 

Method of Collection 

Participants will be screened for 

eligibility and recruited for the focus 

groups by telephone. The focus group 

sessions will be conducted in-person 

with approximately 10 persons per 

group. The focus group discussion will 

take approximately 2 hours, and we 

have assumed a 20-minute travel time 

(each way) per participant. Thus, focus 

group participation will require 2.67 

hours per response. 

Estimated Annual Respondent Burden 

TABLE 1.—ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

Recruiting Screener ......................................................................................... 2,200 1 5/60 183 

Focus Group Discussion Guide ....................................................................... 220 1 2.67 587 

Total ................................................................................................................. 2,420 na na 770 

TABLE 2.—ESTIMATED ANNUALIZED COST BURDEN

Form name Number of 

respondents 

Total burden 

hours 

Average 

hourly wage 

rate* 

Total cost 

burden 

Recruiting Screener ......................................................................................... 2,200 183 $17 $3,111 

Focus Group Discussion Guide ....................................................................... 220 587 17 9,979 

Total ................................................................................................................. 2,420 770 na 13,090 

*Based upon the mean hourly wage of full-time workers, third-quarter of 2007. Current Population Survey, U.S. Department of Labor, Bureau 

of Labor Statistics. 

Estimated Annual Costs to the Federal 

Government 

Based on the current budget for the 

project, the total cost to the Federal 

Government is $257,474 ($251,114 of 

contractor costs + $6,360 of travel and 

time cost for AHRQ employees) for the 

18-month period from Oct. 1st, 2007 to 

March 31st, 2009. The annualized cost 

is approximately $171,649. This amount 

includes all direct and indirect costs of 

the design, data collection, analysis, and 

reporting phases of the study. The costs 

of Federal employees for monitoring the 

contract are $5,660. 

Request for Comments 

In accordance with the above-cited 

Paperwork Reduction Act legislation, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: December 17, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–6188 Filed 12–27–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency For Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the Announcement of 

Availability of Funds for Grants 

regarding National Research Service 

Award Institutional Research Training 

Grant (T32) applications are to be 

reviewed and discussed at this meeting. 

These discussions are likely to reveal 

personal information concerning 

individuals associated with the 

applications. This information is 

exempt from mandatory disclosure 

under the above-cited statutes. 

SEP Meeting on: National Research 

Service Award Institutional Research 

Training Grant (T32) applications. 

Date: January 31–February 1, 2008 

(Open on January 31 from 8:30 a.m. to 

8:45 a.m. and closed for the remainder 

of the meeting). 

Place: Gaithersburg Marriott 

Washingtonian Center, Marriott 

mstockstill on PROD1PC66 with NOTICES

73828 Federal Register / Vol. 72, No. 248 / Friday, December 28, 2007 / Notices 

Conference Center, 9751 Washingtonian 

Blvd., Gaithersburg, MD 20878. 

Contact Person: Anyone wishing to 

obtain a roster of members, agenda or 

minutes of the non-confidential portions 

of this meeting should contact Mrs. 

Bonnie Campbell, Committee 

Management Officer, Office of 

Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone (301) 427–

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

Dated: December 19, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–6216 Filed 12–27–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[ATSDR–237] 

Identification Of Priority Data Needs 

for Six Priority Hazardous Substances 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), U.S. 

Department of Health and Human 

Services (HHS). 

ACTION: Request for public comments on 

the identification of priority data needs 

for six priority hazardous substances 

and an ongoing call for voluntary 

research proposals. 

SUMMARY: This notice makes available 

for public comment the priority data 

needs for six priority hazardous 

substances (see Table 1) as part of the 

continuing development and 

implementation of the ATSDR 

Substance-Specific Applied Research 

Program (SSARP). The notice also 

serves as a continuous call for voluntary 

research proposals. 

The exposure and toxicity priority 

data needs in this notice were distilled 

from the data needs identified in 

ATSDR’s toxicological profiles by the 

logical scientific approach described in 

a decision guide published in the 

Federal Register on September 11, 1989 

(54 FR 37618). The priority data needs 

represent essential information to 

improve the database for conducting 

public health assessments. Research to 

address these priority data needs will 

help to determine the types or levels of 

exposure that may present significant 

risks of adverse health effects in people 

exposed to the hazardous substances. 

The priority data needs identified in 

this notice reflect the opinion of 

ATSDR, in consultation with other 

federal programs, about the research 

needed pursuant to ATSDR’s authority 

under the Comprehensive 

Environmental Response, 

Compensation, and Liability Act of 1980 

(Superfund), or CERCLA, as amended 

by the Superfund Amendments and 

Reauthorization Act of 1986 (SARA) [42 

U.S.C. 9604(i)]. The needs identified 

here do not represent the priority data 

needs for any other agency or program. 

Consistent with Section 104(i)(12) of 

CERCLA as amended [42 U.S.C. 

9604(i)(12)], nothing in this research 

program shall be construed to delay or 

otherwise affect or impair the President, 

the Administrator of ATSDR, or the 

Administrator of the Environmental 

Protection Agency (EPA) from 

exercising any authority regarding any 

other provision of law, including the 

Toxic Substances Control Act of 1976 

(TSCA) and the Federal Insecticide, 

Fungicide, and Rodenticide Act of 1972 

(FIFRA), or the response and abatement 

authorities of CERCLA. 

ATSDR worked with other federal 

programs to determine common 

substance-specific data needs and 

mechanisms to implement research that 

may include authorities under TSCA 

and FIFRA, private-sector voluntarism, 

or the direct use of CERCLA funds. 

When deciding the type of research 

that should be done, ATSDR considers 

the recommendations of the Interagency 

Testing Committee (ITC) established 

under Section 4(e) of TSCA. Federally 

funded projects that collect information 

from 10 or more respondents and that 

are funded by cooperative agreements 

are subject to review by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act. If the 

proposed project involves research on 

human subjects, the applicants must 

comply with Department of Health and 

Human Services regulations (45 CFR 

part 46) regarding the protection of 

human subjects. The applicants must 

assure that the project will be subject to 

initial and continuing review by the 

appropriate institutional review 

committees. Overall, by providing 

additional scientific information for the 

risk assessment process, data generated 

from this research will support other 

researchers who are conducting human 

health assessments involving these six 

substances. 

Table 1 presents the priority data 

needs for six priority substances. The 

six substances are included in the 

ATSDR Priority List of Hazardous 

Substances (70 FR 72840, December 7, 

2005). ATSDR invites comments from 

the public on the individual priority 

data needs and the priority data needs 

documents for these substances. After 

considering the comments, ATSDR will 

publish the final priority data needs for 

each substance. These priority data 

needs will be addressed by the 

mechanisms described in the 

‘‘Implementation of Substance-Specific 

Applied Research Program’’ section of 

this Federal Register Notice. 

TABLE 1.—SUBSTANCE-SPECIFIC PRIORITY DATA NEEDS FOR SIX PRIORITY HAZARDOUS SUBSTANCES

Substance Priority data needs 

Aluminum ........................................................................... Exposure levels in humans living near hazardous waste sites. 

Exposure levels in children. 

Dose-response data for acute-duration(1) oral exposure. 

Cresol ................................................................................. Exposure levels in humans living near hazardous waste sites. 

Exposure levels in children. 

Dose-response data for acute-duration(1) oral exposure. 

Diazinon ............................................................................. Developmental toxicity data for oral exposure. 

Dichloropropenes ............................................................... Dose-response data for acute-duration(1) inhalation exposure. 

Immunotoxicity battery via inhalation exposure. 

Guthion ............................................................................... Studies of developmental toxicity via oral exposure with emphasis on 

neurodevelopmental toxicity. 

Phenol ................................................................................ Exposure levels in humans living near hazardous waste sites. 

Exposure levels in children. 

Two-year oral carcinogenicity bioassay. 

(1) 14 days or less. 

mstockstill on PROD1PC66 with NOTICES